Article
Tumor heterogeneity and the potential role of liquid biopsy in bladder cancer
30 Dec 2020
Abstract excerpt
Bladder cancer (BC) is a heterogeneous disease that characterized by genomic instability and a high mutation rate. Heterogeneity in tumor may partially explain the diversity of responses to targeted therapies and the various clinical outcomes. A combination of cytology and cystoscopy is the standard methodology for BC diagnosis, prognosis, and disease surveillance. However, genomics analyses of single...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
